PHARMACOMPASS Grow Your Pharma Bussiness Digitally
Grow Your Pharma Business Digitally
Merck Fosamax case gets another shot at preemption argument
Lilly's rising star Verzenio gets Japanese safety warning
Mallinckrodt sues the feds to fight $600M Acthar rebate bill
Germany’s Evotec expands into biologics with up to $90M deal for Seattle’s J...
Pharma heavy hitters join Verily’s Project Baseline
Array BioPharma's colorectal cancer combo treatment meets main goals
Merck’s Keytruda fails triple negative breast cancer pivotal study
PhIII setback mars Ocular’s glaucoma drug/device, though company remains ‘en...
WuXi to build vaccine plant in deal it values at $3B
Merck buys Peloton to expand its kidney cancer treatment portfolio
Med Co, Alnylam's inclisiran cuts cholesterol long-term
South Africa's Aspen sells Australian prescription portfolio to Mylan
On a hunt for new revenue, Mylan ponies up $130M for Aspen meds
TRC Capital’s mini-tender offer irritates a flustered Biogen
ICER seeks to make drug price research more accessible
U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug
Schrödinger raises more cash, amassing $110M for R&D drive
Boehringer eyes rare disease use for respiratory blockbuster
CSL Behring poaches manufacturing exec from struggling Biogen
Copyright © 2019 LePro PharmaCompass OPC Private Limited, All rights reserved.